share_log

Processa Pharmaceuticals | 8-K: Current report

SEC announcement ·  Apr 5 00:10
Summary by Futu AI
On April 3, 2024, George Ng, CEO of Processa Pharmaceuticals, Inc., presented at the MedInvest Biotech + Pharma Investor Conference in New York City. The presentation, titled 'Next Generation Chemotherapy: Improved Treatment for More Patients,' was delivered at 10:55 AM ET and was attended virtually by Dr. David Young, President of R&D. The presentation materials were uploaded to a portal and furnished as Exhibit 99.1, which is incorporated by reference. Additionally, the presentation will be accessible in the 'Investors' section of Processa's website. The company has stated that it has no obligation to update the information presented, but may do so through various means of public disclosure. Processa uses its website to disclose material non-public information in compliance with Regulation FD.
On April 3, 2024, George Ng, CEO of Processa Pharmaceuticals, Inc., presented at the MedInvest Biotech + Pharma Investor Conference in New York City. The presentation, titled 'Next Generation Chemotherapy: Improved Treatment for More Patients,' was delivered at 10:55 AM ET and was attended virtually by Dr. David Young, President of R&D. The presentation materials were uploaded to a portal and furnished as Exhibit 99.1, which is incorporated by reference. Additionally, the presentation will be accessible in the 'Investors' section of Processa's website. The company has stated that it has no obligation to update the information presented, but may do so through various means of public disclosure. Processa uses its website to disclose material non-public information in compliance with Regulation FD.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.